BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 6328728)

  • 1. Trials of an inactivated equid herpesvirus 1 vaccine: challenge with a subtype 1 virus.
    Burrows R; Goodridge D; Denyer MS
    Vet Rec; 1984 Apr; 114(15):369-74. PubMed ID: 6328728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Viraemia and abortions are not prevented by two commercial equine herpesvirus-1 vaccines after experimental challenge of horses.
    Bürki F; Rossmanith W; Nowotny N; Pallan C; Möstl K; Lussy H
    Vet Q; 1990 Apr; 12(2):80-6. PubMed ID: 2163560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trials of an inactivated equid herpesvirus 1 vaccine: challenge with a subtype 2 virus.
    Mumford JA; Bates J
    Vet Rec; 1984 Apr; 114(15):375-81. PubMed ID: 6328729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Derivation and characterisation of a live equid herpes virus-1 (EHV-1) vaccine to protect against abortion and respiratory disease due to EHV-1.
    Patel JR; Bateman H; Williams J; Didlick S
    Vet Microbiol; 2003 Jan; 91(1):23-39. PubMed ID: 12441229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application of a chemically inactivated, adjuvanted vaccine to control abortigenic infection of mares by equine herpesvirus I.
    Bryans JT; Allen GP
    Dev Biol Stand; 1982; 52():493-8. PubMed ID: 6299858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and virological evaluation of the efficacy of an inactivated EHV1 and EHV4 whole virus vaccine (Duvaxyn EHV1,4). Vaccination/challenge experiments in foals and pregnant mares.
    Heldens JG; Hannant D; Cullinane AA; Prendergast MJ; Mumford JA; Nelly M; Kydd JH; Weststrate MW; van den Hoven R
    Vaccine; 2001 Jul; 19(30):4307-17. PubMed ID: 11457558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serological responses and clinical outcome after vaccination of mares and foals with equine herpesvirus type 1 and 4 (EHV-1 and EHV-4) vaccines.
    Bresgen C; Lämmer M; Wagner B; Osterrieder N; Damiani AM
    Vet Microbiol; 2012 Nov; 160(1-2):9-16. PubMed ID: 22633483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccines for EHV1 abortion.
    Mitchell D
    Vet Rec; 1983 Mar; 112(12):285. PubMed ID: 6302971
    [No Abstract]   [Full Text] [Related]  

  • 9. Equine herpesvirus.
    Vet Rec; 1989 May; 124(19):519. PubMed ID: 2547266
    [No Abstract]   [Full Text] [Related]  

  • 10. Equine herpesvirus 1 infection in mares vaccinated with a live-virus rhinopneumonitis vaccine attenuated in cell culture.
    Eaglesome MD; Henry JN; McKnight JD
    Can Vet J; 1979 May; 20(5):145-7. PubMed ID: 226261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccination of mares against equine herpesvirus-1.
    Pickles AC
    Vet Rec; 1992 Feb; 130(8):167-8. PubMed ID: 1314446
    [No Abstract]   [Full Text] [Related]  

  • 12. [Preventative vaccination against EHV (equine herpesvirus) abortion].
    Becker W
    Tierarztl Prax; 1988; 16(1):61-3. PubMed ID: 2835828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Equid herpesvirus (EHV-1) live vaccine strain C147: efficacy against respiratory diseases following EHV types 1 and 4 challenges.
    Patel JR; Földi J; Bateman H; Williams J; Didlick S; Stark R
    Vet Microbiol; 2003 Mar; 92(1-2):1-17. PubMed ID: 12488066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Towards a vaccine against equine herpesvirus 1.
    Sabine M; Whalley JM
    Aust Vet J; 1989 Dec; 66(12):403-4. PubMed ID: 2559691
    [No Abstract]   [Full Text] [Related]  

  • 15. Pre-infection frequencies of equine herpesvirus-1 specific, cytotoxic T lymphocytes correlate with protection against abortion following experimental infection of pregnant mares.
    Kydd JH; Wattrang E; Hannant D
    Vet Immunol Immunopathol; 2003 Dec; 96(3-4):207-17. PubMed ID: 14592733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Control of EHV-1 viremia and nasal shedding by commercial vaccines.
    Goehring LS; Wagner B; Bigbie R; Hussey SB; Rao S; Morley PS; Lunn DP
    Vaccine; 2010 Jul; 28(32):5203-11. PubMed ID: 20538091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaccination of pregnant ponies against equine rhinopneumonitis.
    Crandell RA; Mock RE; Lock TF
    Am J Vet Res; 1980 Jul; 41(7):994-6. PubMed ID: 6254412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serological responses of mares and weanlings following vaccination with an inactivated whole virus equine herpesvirus 1 and equine herpesvirus 4 vaccine.
    Foote CE; Love DN; Gilkerson JR; Whalley JM
    Vet Microbiol; 2002 Aug; 88(1):13-25. PubMed ID: 12119135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccination of foals and pregnant mares with Duvaxyn EHV1, 4 vaccine.
    Studdert MJ
    Vaccine; 2002 Jan; 20(7-8):992. PubMed ID: 11803056
    [No Abstract]   [Full Text] [Related]  

  • 20. Intranasal IgG4/7 antibody responses protect horses against equid herpesvirus-1 (EHV-1) infection including nasal virus shedding and cell-associated viremia.
    Perkins G; Babasyan S; Stout AE; Freer H; Rollins A; Wimer CL; Wagner B
    Virology; 2019 May; 531():219-232. PubMed ID: 30928700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.